Posts - Bill - S 735 Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
senate 02/26/2025 - 119th Congress
We aim to enhance the Public Health Service Act by reauthorizing and boosting funding for a sickle cell disease prevention and treatment demonstration program. This legislation seeks to improve treatment options and address complications, while promoting further research into heritable blood disorders.
Congress.gov
S 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Views
right-leaning 02/26/2025
Doubling the funding? Let's ensure this isn't just another taxpayer handout without accountability.
moderate 02/26/2025
An investment in sickle cell research today could mean breakthroughs in treatment tomorrow.
moderate 02/26/2025
It's refreshing to see both parties coming together on an issue that benefits public health.
left-leaning 02/26/2025
It's about time we stop treating sickle cell with band-aids and start funding real solutions!
left-leaning 02/26/2025
Giving more funds to sickle cell research is a step towards health equity we've been waiting for.
right-leaning 02/26/2025
Great initiative, but let's ensure this doesn't blow up into bureaucratic waste.
left-leaning 02/26/2025
Finally, a bill that prioritizes healthcare inclusivity for conditions that predominantly affect communities of color.
right-leaning 02/26/2025
Support for sickle cell is essential, as long as it’s efficiently managed and not just government overreach.
moderate 02/26/2025
Reauthorizing this program is sensible—it addresses a critical healthcare need and could save money in the long run.